In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

Know about top innovations that will be part of the national TB elimination programme, help in screening and treatment.

It is five years since Covid-19 crossed borders and it is time to revisit the lessons learnt from its catastrophic nature. The pandemic did put a strain on the global healthcare system, but at the ...

Sometimes test results take days or weeks increasing the chances of transmission and causing treatment delays. Rapid diagnostics tests like Polymerase Chain Reaction (PCR) for TB may be considered a ...

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

Union Health Minister JP Nadda on Monday announced the nationwide expansion of the 100-Day Intensified TB Elimination ...

Union Health Minister announced that the tuberculosis elimination program is not expanded nationwide. He shared that RT-PCR ...

Despite variations by age group and influenza virus type, the 2023-2024 influenza vaccine was protective against outpatient illness in pediatric and adult patients.

Kurnool: Cases of tuberculosis (TB) remain a serious concern in Prakasam district despite ongoing awareness programmes. The ...

As a result of the recognition of the increased impact of these viruses, new vaccines and therapeutic options have been and ...

The global in vitro diagnostics market (IVD) was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027. For instance, in clinical chemistry ...